TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 DKK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
9,391
|
8,345
|
8,541 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
430
|
219
|
229 |
EBITDA |
569
|
354
|
235 |
Total assets |
3,926
|
3,376
|
3,388 |
Current assets |
3,488
|
2,840
|
3,368 |
Current liabilities |
1,268
|
965
|
945 |
Equity capital |
2,502
|
2,246
|
2,276 |
- share capital |
32
|
33
|
36 |
Employees (average) |
4
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
63.7%
|
66.5%
|
67.2% |
Turnover per employee |
2,348
|
2,782
|
2,847 |
Profit as a percentage of turnover |
4.6%
|
2.6%
|
2.7% |
Return on assets (ROA) |
11.0%
|
6.5%
|
6.8% |
Current ratio |
275.1%
|
294.3%
|
356.4% |
Return on equity (ROE) |
17.2%
|
9.8%
|
10.1% |
Change turnover |
1,346
|
556
|
74 |
Change turnover % |
17%
|
7%
|
1% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.